Subcellular localization and distribution of the Breast Resistance Protein Transporter in normal human tissues

Cancer Research

Volumn 61, Issue 8, 2001, Pages 3458-3464

  Maliepaard, Marc ^a   Scheffer, George L ^b   Faneyte, Ian F ^a   Van Gastelen, Margôt A ^a   Pijnenborg, Adriana C L M ^b   Schinkel, Alfred H ^a   Van de Vijver, Marc J ^a   Scheper, Rik J ^b   Schellens, Jan H M ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; MITOXANTRONE; MONOCLONAL ANTIBODY; TOPOTECAN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; COLON; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRAHEPATIC BILE DUCT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; SMALL INTESTINE; SYNCYTIOTROPHOBLAST;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ATP-BINDING CASSETTE TRANSPORTERS; CELL MEMBRANE; COS CELLS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCELLULAR FRACTIONS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0035870289     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. A multidrug resistance transporter from MCF-7 breast cancer cells
2. Atypical multidrug resistance: Breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines
3. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line
4. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance
5. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes
6. The physiological function of drug-transporting P-glycoproteins
7. Structural, mechanistic, and clinical aspects of MRP1
8. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier
9. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier
10. BCRP is localized at the plasma membrane in mitoxantrone and topotecan resistant cell lines
11. Differential expression of DNA topoisomerase II α and -β in P-gp and MRP-negative VM26, mAMSA, and mitoxantrone-resistant sublines of the human SCLC cell line GLC4
12. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line
13. Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line
14. MRP3, an organic anion transporter able to transport anticancer drugs
15. Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies
16. SV40-transformed simian cells support the replication of early SV40 mutants
17. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
18. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies
19. An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein
20. Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies
21. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
22. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis
23. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression
24. An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR
25. A method to monitor mRNA levels in human breast tumor cells obtained by fine-needle aspiration
26. Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: Association with level of drug resistance and drug accumulation
27. The mouse Bcrp1/Mxr/Abcp gene: Amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin
28. Reversal of resistance by GF120918 in cell lines expressing the half-transporter, MXR
29. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan
30. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?
31. Tissue distribution of the multidrug resistance protein
32. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
33. Enhanced oral absorption and decreased elimination of paclitaxel in mice cotreated with cyclosporin A
34. Co-administration of cyclosporin enables oral therapy with paclitaxel
35. Bioavailability and pharmacokinetics of oral topotecan: A new topoisomerase inhibitor